Matt Hewitt

Stock Analyst at Craig-Hallum

(2.68)
# 2,155
Out of 5,032 analysts
40
Total ratings
54.05%
Success rate
3.64%
Average return

Stocks Rated by Matt Hewitt

Simulations Plus
Jun 13, 2025
Maintains: Buy
Price Target: $45$36
Current: $15.39
Upside: +133.92%
Champions Oncology
Mar 12, 2025
Maintains: Buy
Price Target: $8$12
Current: $6.44
Upside: +86.34%
Clover Health Investments
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $2.71
Upside: +121.40%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $30$32
Current: $27.32
Upside: +17.13%
Omnicell
Oct 31, 2024
Maintains: Buy
Price Target: $45$64
Current: $29.90
Upside: +114.05%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25$10
Current: $1.32
Upside: +657.58%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35$30
Current: $19.31
Upside: +55.36%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $1.61
Upside: +334.78%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207$200
Current: $152.60
Upside: +31.06%
OmniAb
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $1.66
Upside: +502.41%
Maintains: Hold
Price Target: $67$30
Current: $8.53
Upside: +251.70%
Initiates: Buy
Price Target: $400
Current: $0.74
Upside: +53,895.68%